Novel dexamethasone formulation shows efficacy and safety with once-daily use
Eric D. Donnenfeld, a consultant to Oculis reported for Ophthalmology Times on the results of a phase 2 trial: dexamethasone
Novel dexamethasone formulation shows efficacy and safety with once-daily use
Eric D. Donnenfeld, a consultant to Oculis reported for Ophthalmology Times on the results of a phase 2 trial: dexamethasone
Non-parenteral formulation of Remdesivir for Covid-19 treatment
Remdesivir exhibits in vitro activity against SARS-CoV-2 and was granted approval for Emergency Use. To maximize delivery to the lungs,
Cyclodextrin-based materials used in oilfield
This review [1] introduces the characteristics of cyclodextrin-based materials, including cyclodextrin polymers, inclusion complexes and new cyclodextrin nanocomposites, and summarizes
Sustained-release antibacterial pads based on nonwovens polyethylene terephthalate modified by β-cyclodextrin embedded with cinnamaldehyde for cold fresh pork preservation
This work [1] aimed to explore the effect of antibacterial pads containing cinnamaldehyde on the shelf life of cold fresh
Coronavirus Interplay With Lipid Rafts and Autophagy Unveils Promising Therapeutic Targets.
The plasma membrane microdomain lipid rafts have been found by researchers to be involved in the replication cycle of numerous
Cyclodextrin-impregnated masks to prevent the transmission of coronavirus
CycloLab’s submission to InnoCentive Challenge 9934291 – New Technologies to Prevent the Transmission of Coronavirus led to a favorable evaluation.
Marinus Awarded BARDA Contract to Develop SBECD-enabled Ganaxolone for Treatment of Refractory Status Epilepticus
Marinus Pharmaceuticals, a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, announced it has
Cyclodextrin counteracts obesity associated with various diseases including susceptibility for Covid-19
Obesity has become a worldwide health crisis and is associated with a plethora of comorbidities. Cardiovascular disease (CVD) and type
Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds: a patent evaluation of US2019343869(A1)
Introduction: Antimicrobial resistance is one of the major scourges for healthcare worldwide, therefore novel investigational approaches are needed to potentiate and
Nitric oxide in the treatment of coronavirus disease (COVID-19)
„Inhaled nitric oxide dilates or widens arteries to allow more blood to flow through the lungs. It also relaxes the